company background image
ELV logo

Elevance Health NYSE:ELV Stock Report

Last Price

US$514.09

Market Cap

US$119.6b

7D

0.3%

1Y

7.9%

Updated

26 Feb, 2024

Data

Company Financials +

ELV Stock Overview

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.

ELV fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Elevance Health, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Elevance Health
Historical stock prices
Current Share PriceUS$514.09
52 Week HighUS$515.35
52 Week LowUS$412.00
Beta0.78
1 Month Change6.26%
3 Month Change8.12%
1 Year Change7.93%
3 Year Change65.05%
5 Year Change75.70%
Change since IPO2,413.89%

Recent News & Updates

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Feb 19
Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Jan 26

Recent updates

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Feb 19
Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Jan 26

Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Jan 19
Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Is Elevance Health (NYSE:ELV) A Risky Investment?

Jan 02
Is Elevance Health (NYSE:ELV) A Risky Investment?

Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

Dec 18
Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

A Look At Elevance's Margin Dynamics

Nov 23

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Nov 16
Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Elevance Health: A High Conviction Defensive Blue Chip Buy

Oct 19

These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Oct 04
These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Elevance: Pave The Way For The Next UnitedHealth

Sep 21

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Sep 18
Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Here's The Price I Would Buy Elevance Health Stock

Sep 13

If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Aug 18
If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Aug 04
Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental

Jul 24

Elevance Health: Beaten Down Share Price Offers Solid Potential

Jul 10

Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Jul 05
Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Elevance Health: A Critical Update (Rating Downgrade)

Jun 05

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Jun 04
Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

May 05
Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Apr 04
We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48

Feb 17
Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Feb 13
Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Elevance Health: Attractive On Its Expansion Catalysts

Feb 09

Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48

Jan 28
Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48

Elevance Health acquiring Blue Cross and Blue Shield of Louisiana

Jan 23

Elevance Health Offers Great Value

Jan 17

At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?

Jan 17
At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?

Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name

Jan 02

Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly

Nov 28
Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly

Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?

Nov 16
Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?

Elevance Health to acquire speciality pharmacy from CarepathRx

Nov 09

Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price

Nov 02
Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price

Elevance Health declares $1.28 dividend

Oct 19

Are Investors Undervaluing Elevance Health Inc. (NYSE:ELV) By 37%?

Oct 12
Are Investors Undervaluing Elevance Health Inc. (NYSE:ELV) By 37%?

Elevance affiliates to offer affordable Medicare Advantage plans

Oct 10

Molina, Elevance, Centene win Medicare contracts in California

Aug 26

Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly

Aug 25
Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly

Elevance Health: Continues To Grow, A Strong Buy

Aug 18

What Does Elevance Health Inc.'s (NYSE:ELV) Share Price Indicate?

Aug 13
What Does Elevance Health Inc.'s (NYSE:ELV) Share Price Indicate?

Elevance Health (NYSE:ELV) Shareholders Will Want The ROCE Trajectory To Continue

Aug 01
Elevance Health (NYSE:ELV) Shareholders Will Want The ROCE Trajectory To Continue

Elevance Health declares $1.28 dividend

Jul 20

Do Elevance Health's (NYSE:ELV) Earnings Warrant Your Attention?

Jul 18
Do Elevance Health's (NYSE:ELV) Earnings Warrant Your Attention?

Are Investors Undervaluing Elevance Health Inc. (NYSE:ELV) By 38%?

Jul 04
Are Investors Undervaluing Elevance Health Inc. (NYSE:ELV) By 38%?

Anthem's Gains Weaken The Bull Case

Jun 01

Is It Too Late To Consider Buying Anthem, Inc. (NYSE:ANTM)?

May 09
Is It Too Late To Consider Buying Anthem, Inc. (NYSE:ANTM)?

Does Anthem (NYSE:ANTM) Have A Healthy Balance Sheet?

Apr 25
Does Anthem (NYSE:ANTM) Have A Healthy Balance Sheet?

Shareholder Returns

ELVUS HealthcareUS Market
7D0.3%0.7%1.3%
1Y7.9%4.6%25.6%

Return vs Industry: ELV exceeded the US Healthcare industry which returned 4.6% over the past year.

Return vs Market: ELV underperformed the US Market which returned 25.6% over the past year.

Price Volatility

Is ELV's price volatile compared to industry and market?
ELV volatility
ELV Average Weekly Movement2.1%
Healthcare Industry Average Movement6.6%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: ELV has not had significant price volatility in the past 3 months.

Volatility Over Time: ELV's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001104,900Gail Boudreauxhttps://www.elevancehealth.com

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

Elevance Health, Inc. Fundamentals Summary

How do Elevance Health's earnings and revenue compare to its market cap?
ELV fundamental statistics
Market capUS$119.61b
Earnings (TTM)US$5.99b
Revenue (TTM)US$171.34b

20.0x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ELV income statement (TTM)
RevenueUS$171.34b
Cost of RevenueUS$124.33b
Gross ProfitUS$47.01b
Other ExpensesUS$41.02b
EarningsUS$5.99b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)25.73
Gross Margin27.44%
Net Profit Margin3.49%
Debt/Equity Ratio63.7%

How did ELV perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

23%

Payout Ratio

Does ELV pay a reliable dividends?

See ELV dividend history and benchmarks
When do you need to buy ELV by to receive an upcoming dividend?
Elevance Health dividend dates
Ex Dividend DateMar 07 2024
Dividend Pay DateMar 22 2024
Days until Ex dividend9 days
Days until Dividend pay date24 days

Does ELV pay a reliable dividends?

See ELV dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.